State Street Corp raised its stake in Entrada Therapeutics, Inc. (NASDAQ:TRDA – Free Report) by 5.5% during the 3rd quarter, according to the company in its most recent disclosure with the Securities ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback